手法を比較
選択した手法を並べて確認できます。異なる行はハイライト表示されます。
| 人獣共通感染症サーベイランス× | 獣医学における抗菌薬感受性試験× | |
|---|---|---|
| 分野 | 獣医学 | 獣医学 |
| 系統 | Process / pipeline | Process / pipeline |
| 提唱年≠ | 1900s-present | 1960s-present |
| 提唱者≠ | Veterinary epidemiology and public health | Clinical Laboratory Standards Institute (CLSI) and veterinary microbiology |
| 種類≠ | Population-level monitoring pipeline | Diagnostic laboratory pipeline |
| 原典≠ | Kahn, C. M. (Ed.). (2002). The Merck Veterinary Manual (9th ed.). Whitehouse Station, NJ: Merck. link ↗ | Clinical and Laboratory Standards Institute (CLSI). (2023). Performance Standards for Antimicrobial Susceptibility Testing of Bacteria Isolated from Animals (CLSI M100, 4th ed., Veterinary Supplement). Wayne, PA: CLSI. link ↗ |
| 別名 | disease monitoring, epidemiological surveillance, public health surveillance | antibiotic sensitivity testing, MIC determination, resistance profiling |
| 関連 | 3 | 3 |
| 概要≠ | Zoonotic disease surveillance is a systematic population-level monitoring approach that detects, tracks, and analyzes cases of infectious diseases transmissible between animals and humans. Formalized through veterinary epidemiology and integrated with public health systems since the early 1900s, modern surveillance programs employ case detection networks, laboratory confirmation, and data sharing to enable early warning of emerging threats and coordinated disease prevention across animal and human sectors. | Antimicrobial susceptibility testing (AST) is a systematic in vitro laboratory method that determines which antimicrobial agents are effective against an isolated bacterial or fungal pathogen. Standardized by the Clinical and Laboratory Standards Institute (CLSI) and other regulatory bodies since the 1960s, AST guides targeted therapeutic decisions, supports infection control, and generates epidemiological data on resistance patterns essential for combating antimicrobial resistance in animal populations. |
| ScholarGateデータセット ↗ |
|
|